Buy Three, Get the Fourth Free! | Start Saving >>
12324
SignalSilence® p27 Kip1 siRNA I
siRNA

SignalSilence® p27 Kip1 siRNA I #12324

Western Blotting

Western blot analysis of extracts from HeLa cells, transfected with 100 nM SignalSilence® Control siRNA (Unconjugated) #6568 (-), SignalSilence® p27 Kip1 siRNA I (+), or SignalSilence® p27 Kip1 siRNA II #12410 (+), using p27 Kip1 (D69C12) XP® Rabbit mAb #3686 (upper) or β-Actin (D6A8) Rabbit mAb #8457 (lower). The p27 Kip1 (D69C12) XP® Rabbit mAb confirms silencing of p27 Kip1 expression, while the β-Actin (D6A8) Rabbit mAb is used as a loading control.

Learn more about how we get our images

CST recommends transfection with 100 nM SignalSilence® p27 Kip1 siRNA I 48 to 72 hours prior to cell lysis. For transfection procedure, follow protocol provided by the transfection reagent manufacturer. Please feel free to contact CST with any questions on use.

Each vial contains the equivalent of 100 transfections, which corresponds to a final siRNA concentration of 100 nM per transfection in a 24-well plate with a total volume of 300 μl per well.

Storage:

SignalSilence® siRNA is supplied in RNAse-free water. Aliquot and store at -20ºC.

SignalSilence® p27 Kip1 siRNA I from Cell Signaling Technology (CST) allows the researcher to specifically inhibit p27 Kip1 expression using RNA interference, a method whereby gene expression can be selectively silenced through the delivery of double stranded RNA molecules into the cell. All SignalSilence® siRNA products from CST are rigorously tested in-house and have been shown to reduce target protein expression by western analysis.

Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.

p27 Kip1 is a member of the Cip/Kip family of cyclin-dependent kinase inhibitors. Like its relatives, p57 Kip2 and p21 Waf1/Cip1, the ability to enforce the G1 restriction point is derived from its inhibitory binding to CDK2/cyclin E and other CDK/cyclin complexes. Expression levels of p27 are upregulated in quiescent cells and in cells treated with cAMP or other negative cell cycle regulators. Downregulation of p27 can be induced by treatment with interleukin-2 or other mitogens; this involves phosphorylation of p27 and its degradation by the ubiquitin-proteasome pathway (1-4).

  1. Lloyd, R.V. et al. (1999) Am J Pathol 154, 313-23.
  2. Polyak, K. et al. (1994) Genes Dev 8, 9-22.
  3. Kato, J.Y. et al. (1994) Cell 79, 487-96.
  4. Vlach, J. et al. (1997) EMBO J 16, 5334-44.
Entrez-Gene Id
1027
Swiss-Prot Acc.
P46527
For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
SignalSilence is a registered trademark of Cell Signaling Technology, Inc.

Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Important Ordering Details

Custom Ordering Details: Product is assembled upon order. Please allow up to three business days for your product to be processed.

To Purchase # 12324S

View sizes
Product # Size Price
12324S
300 µl (3 nmol) $ 256.0